Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For RCII
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 5.68 0.49 0.46
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 24.02 2.69 2.17
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value -5.23 10.51 11.08
Cash 20.91 1.86 1.54
Capex 0.00 0.00 0.00
Free Cash Flow -0.52 0.22 0.22
Revenue -0.74 17.22 17.35
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -1.78 0.51 0.52
Operating Margin -30.91 0.06 0.09
ROA -90.58 < 0.005 -0.02
ROE -89.98 < 0.005 -0.07
ROIC -87.69 < 0.005 -0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of RCII is permitted for members.
5 Growth
The "Growth Entry" for the Focus of RCII is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of RCII is permitted for members.